CVRx to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call on August 6, 2026GlobeNewsWire • 07/23/26
CVRx, Inc. (CVRX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 TranscriptSeeking Alpha • 06/10/26
CVRx to Present at the Goldman Sachs 47th Annual Global Healthcare ConferenceGlobeNewsWire • 05/27/26
CVRx Announces Humana Medicare Advantage Coverage Policy for Barostim TherapyGlobeNewsWire • 05/14/26
Down 31.7% in 4 Weeks, Here's Why You Should You Buy the Dip in CVRx (CVRX)Zacks Investment Research • 05/13/26
CVRx Announces First Patient Enrollment in BENEFIT-HF, a Landmark Heart Failure Trial Evaluating Barostim in Significantly Expanded PopulationGlobeNewsWire • 05/04/26
CVRx (CVRX) Could Find a Support Soon, Here's Why You Should Buy the Stock NowZacks Investment Research • 05/01/26
CVRx to Report First Quarter 2026 Financial and Operating Results and Host Conference Call on May 11, 2026GlobeNewsWire • 04/27/26
CVRx Announces Nomination of Michael Dale for Election to the Board of DirectorsGlobeNewsWire • 04/20/26
Securities Fraud Investigation Into CVRx, Inc. (CVRX) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law FirmBusiness Wire • 03/17/26
Securities Fraud Investigation Into CVRx, Inc. (CVRX) Continues – Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. CruzBusiness Wire • 03/17/26
CVRx Announces Late-Breaking Data and Scientific Presentations Highlighting Barostim Outcomes at the THT 2026 Annual MeetingGlobeNewsWire • 03/02/26
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CVRx, Inc. - CVRXGlobeNewsWire • 02/24/26
Securities Fraud Investigation Into CVRx, Inc. (CVRX) Announced – Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. CruzBusiness Wire • 02/19/26